IISG has developed a strong portfolio of next-generation antibody therapies to treat a spectrum of cancer and eye indications
via targeting multiple intracellular oncoproteins.
Milestones
2008
new concept on Cancer Immunotherapy
2017
Phase I clinical trial on solid tumor & Hematological malignancies in Singapore
2019
Phase II clinical trial on solid tumor in Singapore
2020
Phase II clinical trial on solid tumor in USA
2021
Phase II clinical trial on solid tumor in CHINA
2023
Phase II/III clinical trial on solid tumor in Malaysia
2025
Phase I/II clinical trial on neovascular age related macular degeneration in Singapore
Clinical Trials
-
2017
Phase IA & B Solid Cancer Clinical Trial in Singapore:
-
2019
Phase Ib Liquid Cancer Clinical trial in Singapore:
-
2019
Phase II Solid Cancer Clinical Trial in Singapore
-
2020
Phase II Solid Cancer Clinical Trial In USA
-
2021
Phase II Solid Cancer Clinical Trial in China
-
2023
Phase II/III Solid Cancer Clinical Trial in Malaysia
-
2025
Phase II/III Wet AMD Clinical Trial in Singapore